Table 2 Overview of differences in estimated survival time, hospital length of stay (LOS) and progression to adjuvant chemotherapy for the studied outcomes. Hospital LOS is reported as medians [interquartile range, IQR]
Perioperative transfusions | p-value | Anesthesia technique | p-value | Analgesia technique | p- value | ||||
|---|---|---|---|---|---|---|---|---|---|
Survival time* (months) | Yes | No | TIVA | IV + Inhalation | Epidural | No epidural | |||
12 | 66.7% | 82.5% | NA | 72.4% | 82.8% | NA | 81.8% | 71.7% | NA |
24 | 46.6% | 60.9% | NA | 51.5% | 63.5% | NA | 58.7% | 56.5% | NA |
48 | 23.9% | 34.1% | NA | 21.5% | 39.6% | NA | 34.9% | 24.1% | NA |
72 | 8.8% | 28.0% | NA | 19.9% | 27.3% | NA | 27.0% | 17.0% | NA |
Hospital length of stay (days) | 11[6–20] | 10[7–18] | 0.512 | 10[7–19] | 12[6–23] | 0.917 | 10[7–18] | 10[6–17] | 0.818 |
Progression to adjuvant chemotherapy (n,%) | 61(72.6) | 309(65.3) | 0.204 | 216(79.1) | 154(90.5) | 0.525 | 290(77.7) | 80(80.8) | 0.603 |